BRENNA JAMES: Open Payments
NPI 1427782952 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 41 payments from 12 companies in 2025. Trend: 2023 $47 · 2024 $720 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $311 |
| AstraZeneca Pharmaceuticals LP | 8 | $174 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Lilly USA, LLC | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Abbott Laboratories | 2 | $35 |
| Novo Nordisk Inc | 2 | $33 |
| PFIZER INC. | 2 | $31 |
| SANOFI-AVENTIS U.S. LLC | 2 | $28 |
| Gilead Sciences, Inc. | 1 | $16 |
Products named: QULIPTA, AIRSUPRA, CAPLYTA, VRAYLAR, BREZTRI, MOUNJARO, TRELEGY ELLIPTA, FREESTYLE LIBRE 3.
Industry payments across AZ — which companies pay providers there.
